OpenURL Connection Search

Select item for more details and to access through your institution.

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation.
Published in:
Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00872-4
By:
- Li, Lijin;
- Zhang, Xiuli;
- Wang, Xiaoli;
- Kim, Samuel W.;
- Herndon, John M.;
- Becker-Hapak, Michelle K.;
- Carreno, Beatriz M.;
- Myers, Nancy B.;
- Sturmoski, Mark A.;
- McLellan, Michael D.;
- Miller, Christopher A.;
- Johanns, Tanner M.;
- Tan, Benjamin R.;
- Dunn, Gavin P.;
- Fleming, Timothy P.;
- Hansen, Ted H.;
- Goedegebuure, S. Peter;
- Gillanders, William E.
Publication type:
Article
Cancer Genome Sequencing and Its Implications for Personalized Cancer Vaccines.
Published in:
Cancers, 2011, v. 3, n. 4, p. 4191, doi. 10.3390/cancers3044191
By:
- Li, Lijin;
- Goedegebuure, Peter;
- Mardis, Elaine R.;
- Ellis, Matthew J. C.;
- Xiuli Zhang;
- Herndon, John M.;
- Fleming, Timothy P.;
- Carreno, Beatriz M.;
- Hansen, Ted H.;
- Gillanders, William E.
Publication type:
Article
Apoptosis, tolerance, and regulatory T cells – old wine, new wineskins.
Published in:
Immunological Reviews, 2003, v. 193, n. 1, p. 111, doi. 10.1034/j.1600-065X.2003.00042.x
By:
- Ferguson, Thomas A.;
- Stuart, Patrick M.;
- Herndon, John M.;
- Griffith, Thomas S.
Publication type:
Article
Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion.
Published in:
2021
By:
- Sankpal, Narendra V.;
- Brown, Taylor C.;
- Fleming, Timothy P.;
- Herndon, John M.;
- Amaravati, Anusha A.;
- Loynd, Allison N.;
- Gillanders, William E.
Publication type:
journal article
Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies.
Published in:
Science Translational Medicine, 2019, v. 11, n. 499, p. 1, doi. 10.1126/scitranslmed.aau9240
By:
- Panni, Roheena Z.;
- Herndon, John M.;
- Zuo, Chong;
- Hegde, Samarth;
- Hogg, Graham D.;
- Knolhoff, Brett L.;
- Breden, Marcus A.;
- Li, Xiaobo;
- Krisnawan, Varintra E.;
- Khan, Samia Q.;
- Schwarz, Julie K.;
- Rogers, Buck E.;
- Fields, Ryan C.;
- Hawkins, William G.;
- Gupta, Vineet;
- DeNardo, David G.
Publication type:
Article
Pollock: fishing for cell states.
Published in:
Bioinformatics Advances, 2022, v. 2, n. 1, p. 1, doi. 10.1093/bioadv/vbac028
By:
- Storrs, Erik P;
- Zhou, Daniel Cui;
- Wendl, Michael C;
- Wyczalkowski, Matthew A;
- Karpova, Alla;
- Wang, Liang-Bo;
- Li, Yize;
- Southard-Smith, Austin;
- Jayasinghe, Reyka G;
- Yao, Lijun;
- Liu, Ruiyang;
- Wu, Yige;
- Terekhanova, Nadezhda V;
- Zhu, Houxiang;
- Herndon, John M;
- Puram, Sid;
- Chen, Feng;
- Gillanders, William E;
- Fields, Ryan C;
- Ding, Li
Publication type:
Article
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
Published in:
NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00500-3
By:
- Ademuyiwa, Foluso O.;
- Gao, Feng;
- Street, Cherease R.;
- Chen, Ina;
- Northfelt, Donald W.;
- Wesolowski, Robert;
- Arora, Mili;
- Brufsky, Adam;
- Dees, E. Claire;
- Santa-Maria, Cesar A.;
- Connolly, Roisin M.;
- Force, Jeremy;
- Moreno-Aspitia, Alvaro;
- Herndon, John M.;
- Carmody, Madelyn;
- Davies, Sherri R.;
- Larson, Sarah;
- Pfaff, Kathleen L.;
- Jones, Stephanie M.;
- Weirather, Jason L.
Publication type:
Article

Found: 7

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation.

Cancer Genome Sequencing and Its Implications for Personalized Cancer Vaccines.

Apoptosis, tolerance, and regulatory T cells – old wine, new wineskins.

Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion.

Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies.

Pollock: fishing for cell states.

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.